FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2132219 · Received June 14, 2011

Report

Report Number
2017233-2011-00276
Event Type
Injury
Date Received
June 14, 2011
Date of Event
May 23, 2011
Report Date
June 13, 2011
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. RESULTS - THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASEE SPECIFICATIONS. CONCLUSIONS - AS STATED IN THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU), THE SAFETY AND EFFECTIVENESS OF THE GORE EXCLUDER AAA ENDOPROSTHESIS HAVE NOT BEEN EVALUATED IN PTS WITH PROXIMAL AORTIC NECK ANGULATIONS EXCEEDING 60 DEGREES. COMPLICATIONS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO, ENDOLEAK.

Description of Event or Problem · 1

ON (B)(6) 2011, THE PT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM USING GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING THE C3 DELIVERY SYSTEM. THE AORTIC NECK WAS HIGHLY ANGLED, MEASURING ABOUT 70 DEGREES. COMPLETION ANGIOGRAPHY SHOWED NO EVIDENCE OF ENDOLEAK. THE PT TOLERATED THE PROCEDURE WELL. ON (B)(6) 2011, AN INTERVENTION OCCURRED TO TREAT A PROXIMAL TYPE-1 ENDOLEAK. THE PT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA AORTIC EXTENDER ENDOPROSTHESES. THE ENDOLEAK WAS RESOLVED. THE PT TOLERATED THE PROCEDURE WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC, ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES WLG425 8589475

Patients

Seq Age Sex Outcome Treatment
1 80 YR Hospitalization| R ASPIRIN| METOPROLOL| PLAVIX| LISINOPROL| VYTORIN